OPTIMAL: Titration of anti-IL5 biologics in severe asthma - An open label randomised controlled trial. Soendergaard MB, Bjerrum AS, Rasmussen LM, Lock-Johansson S, et al. Eur Respir J 2024 Jun 6:2400404. doi: 10.1183/13993003.00404-2024.

Read + Share

Amedeo Smart

Independent Medical Education

Soendergaard MB, Bjerrum AS, Rasmussen LM, Lock-Johansson S, et al. OPTIMAL: Titration of anti-IL5 biologics in severe asthma - An open label randomised controlled trial. Eur Respir J 2024 Jun 6:2400404. doi: 10.1183/13993003.00404-2024.
PMID: 38843910